Danske Bank
EW icon

Danske Bank’s Edwards Lifesciences EW Stock Holding History

Danske Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32.1M Sell
371,301
-153,189
-29% -$13.6M 0.06% 245
2026
Q2 		$47.4M Sell
524,490
-10,234
-2% -$857K 0.09% 173
2026
Q1 		$42.8M Buy
534,724
+188,201
+54% +$15.5M 0.1% 166
2025
Q4 		$29.5M Buy
346,523
+32,200
+10% +$2.64M 0.07% 234
2025
Q3 		$24.4M Buy
314,323
+10,010
+3% +$782K 0.06% 264
2025
Q2 		$23.8M Buy
304,313
+27,400
+10% +$2.04M 0.06% 258
2025
Q1 		$20.1M Sell
276,913
-50,375
-15% -$3.61M 0.06% 267
2024
Q4 		$24.2M Buy
327,288
+45,075
+16% +$3.15M 0.07% 240
2024
Q3 		$18.6M Sell
282,213
-135,834
-32% -$9.9M 0.06% 262
2024
Q2 		$38.6M Buy
418,047
+122,639
+42% +$10.9M 0.14% 129
2024
Q1 		$28.2M Buy
+295,408
New +$24.8M 0.09% 199

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Danske Bank's EW Position: Q3 2026 in Review

Danske Bank reduced its Edwards Lifesciences (EW) stake by 29% in Q3 2026, selling an estimated $13.6M and leaving 371,301 shares worth $32.1M. The position accounts for 0.06% of the portfolio, ranked #245.

Danske Bank first reported a position in EW in Q1 2024 and has held it in 11 quarters since. The position peaked at $47.4M in Q2 2026. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Danske Bank held 371,301 shares of Edwards Lifesciences worth $32.1M as of Q3 2026.
  • Danske Bank sold 153,189 Edwards Lifesciences shares in Q3 2026, an estimated $13.6M.
  • Edwards Lifesciences made up 0.06% of Danske Bank's portfolio in Q3 2026, its #245 holding.
  • Danske Bank first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 11 quarters since.
  • Danske Bank's Edwards Lifesciences position peaked at $47.4M in Q2 2026.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.